Find a Tender · Contract
NP33922 Ranibizumab
A public procurement published by The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") via Find a Tender.
- —
- Award value
- £15.8m
- Tender value
- 2
- Suppliers
- 2
- Awards
- 2
- Notices
- Contract
- Stage
Overview
Supply of ranibizumab injections to NHS Scotland.
Key details
- Source
- Find a Tender
- Lifecycle stage
- Contract
- Status
- active
- CPV classification
- 33600000 — Pharmaceutical products
- Currency
- GBP
- Total award value
- —
- Tender value
- £15,810,833
- First published
- 23 Feb 2022
- Last updated
- 10 Jun 2022
Awards
2 awards recorded on this procurement.
| Supplier | Companies House | Awarded | Status | Value |
|---|---|---|---|---|
| Teva UK Limited | 00302461 | — | active | — |
| Novartis Pharmaceuticals UK Ltd | 00119006 | — | active | — |
Notice timeline
Every published notice in this procurement's lifecycle.
All suppliers
Frameworks & programmes
More from The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
FAQs about this procurement
Who is the buyer for "NP33922 Ranibizumab"?
NP33922 Ranibizumab is a UK public-sector procurement published by The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") via Find a Tender.
Has "NP33922 Ranibizumab" been awarded?
Yes — 2 awards are recorded, with a reported total value of £15,810,833. The current lifecycle stage is "Contract".
Which suppliers are involved in "NP33922 Ranibizumab"?
2 suppliers are linked: Teva UK Limited, Novartis Pharmaceuticals UK Ltd.
What is "NP33922 Ranibizumab" worth?
The reported tender value is £15,810,833.
When was "NP33922 Ranibizumab" published?
It was first published on 23 Feb 2022 and last updated on 10 Jun 2022, across 2 notices.
Track procurements like this one
Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.
Get in touch with Enable